DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Stock

Certificat

DE000ME9LNB8

Market Closed - Börse Stuttgart 02:54:27 2024-06-07 pm EDT
0.3 EUR 0.00% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Current month-14.29%
1 month-9.09%
Date Price Change
24-06-07 0.3 0.00%
24-06-06 0.3 -3.23%
24-06-05 0.31 +10.71%
24-06-04 0.28 -12.50%
24-06-03 0.32 -8.57%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 02:54 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN ME9LNB
ISINDE000ME9LNB8
Date issued 2024-03-05
Strike 85 $
Maturity 2024-12-20 (195 Days)
Parity 10 : 1
Emission price 0.31
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.52
Lowest since issue 0.23
Spread 0.01
Spread %3.33%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
73.2 USD
Average target price
90.35 USD
Spread / Average Target
+23.43%
Consensus